In addition to lipid levels, statins are known to have anti-inflammatory, anti-thrombotic and immunomodulatory effects which could help explain their impact on cardiovascular outcomes. But do these pleiotropic effects matter, or is ta all down to lipid lowering? At the University of Iowa, Jennifer Robinson has been trying to find out.
[audio:https://www.audiomedica.com/podcasting/aha2005/Jennifer_Robinson.mp3]
CIBIS-3 Study: ACE Inhibitor before Beta Blocker for Congestive Heart Failure? 12 Sep, 2005 Raw Deal for European Women with Coronary Artery Disease 12 Sep, 2005 
GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins 16 Nov, 2012 Audio Journal of Cardiovascular Medicine: Reduced Mortality and Repeat MI with Enoxaparin for Patients with ST Elevation Myocardial Infarction 14 May, 2007 
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014